The algorithm sorts patients into groups, who need grading and don't need grading. The ophthalmologists in the team/system can then focus on diagnosing and treating patients who actually need their time. In this way, RetinaLyze® reduces up to 60% of the manual workload.
RetinaLyze® provides instant results on automated screenings for Diabetic Retinopathy, Age-related Macular Degeneration and Glaucoma. The built-in telemedicine platform also allows operators to communicate with remote graders to receive manual assessments.
Security is important to us. As standard, all communication is encrypted. A middle man won’t be able to view or edit images, results or the client information. RetinaLyze is CE-marked and uses the highest level of encryption available today.
RetinaLyze® is a simple system and has been developed with the aim of being easy to use and easy to learn for clinicians as well as non-clinicians. The system can be easily adapted to fit the needs for a single retail store or clinic, a large chain of optometrists or hospitals as well as a rural screening camp.
2018 was quite a year for RetinaLyze System A/S (Ltd.). We launched the glaucoma-algorithm, gave RetinaLyze a visual overhaul and reached 1 million screenings for Diabetic Retinopathy, AMD and Glaucoma!
RetinaLyze teams up with two universities to develop the next generation of eye screening algorithms, which may detect new diseases in retinal images, such as Alzheimer's.
The Rotary Medical Mission (RMM) is in Malawi to provide free eye services including provision of eye and sun glasses, and check ups. Our Head of Global Sales, Lasse Bundgaard, joined them in Lilongwe, Malawi at the Kamuzu Central Hospital.